Appointment of Strategic CEO to Lead Commercial Launch
Filed with ASX · · 2 pages · English
BCAL Diagnostics Limited on 6ix
In the deck
Earlier from BCAL Diagnostics
- Share Purchase Plan Offer Booklet
- Preliminary Final Report
- $2.4m Capital Raise to Further BREASTEST Commercialisation
- Breakthrough Results a Major Step Towards Commercialisation
- BCAL Enters US Product Development Agreement with Precion
Later from BCAL Diagnostics
- Pause in Trading
- Trading Halt
- Response to ASX Price Query
- Suspension from Quotation
- Reinstatement to Quotation
Follow BCAL Diagnostics into a list and get an email when it puts out news.
Follow BCAL Diagnostics